Long-term obeticholic acid treatment is associated with improvements in collagen morphometry in patients with primary biliary cholangitis

被引：0
|
作者：
Kremer, Andreas E. [1 ]
Bowlus, Christopher [2 ]
Bedossa, Pierre [3 ]
Pares, Albert [4 ]
Forman, Lisa [5 ]
Drenth, Joost Ph [6 ]
Ryder, Stephen [7 ]
Terracciano, Luigi Maria [8 ]
Jin, Yuying [9 ]
Liberman, Alexander [9 ]
Pencek, Richard [9 ]
Macconell, Leigh [9 ]
Pockros, Paul [10 ,11 ]
机构：
[1] Friedrich Alexander Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany
[2] Univ Calif Davis, Sacramento, CA 95817 USA
[3] Univ Paris Diderot, Dept Pathol Physiol & Imaging, Paris, France
[4] Univ Barcelona, Hosp Clin, CIBERehd, IDIBAPS, Barcelona, Spain
[5] Univ Colorado, Div Gastroenterol Hepatol, Aurora, CO USA
[6] Radboud Univ Nijmegen, Dept Gastroenterol & Hepatol, Med Ctr, Nijmegen, Netherlands
[7] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Queens Med Ctr, Nottingham, England
[8] Univ Basel, Dept Pathol, Basel, Switzerland
[9] Intercept Pharmaceut Inc, San Diego, CA USA
[10] Scripps Clin, La Jolla, CA USA
[11] Scripps Translat Sci Inst, Div Gastroenterol Hepatol, La Jolla, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30783-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-033
引用
收藏
页码：E398 / E398
页数：1
相关论文
共 50 条
  • [1] LONG-TERM OBETICHOLIC ACID TREATMENT IS ASSOCIATED WITH IMPROVEMENTS IN COLLAGEN MORPHOMETRY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
    Kremer, Andreas E.
    Bowlus, Christopher L.
    Bedossa, Pierre
    Pares, Albert
    Forman, Lisa M.
    Drenth, Joost
    Ryder, Stephen D.
    Terracciano, Luigi
    Jin, Yuyng
    Liberman, Alexander
    Pencek, Richard
    MacConell, Leigh
    Pockros, Paul J.
    GASTROENTEROLOGY, 2019, 156 (06) : S1211 - S1211
  • [2] OBETICHOLIC ACID TREATMENT IS ASSOCIATED WITH IMPROVED COLLAGEN MORPHOMETRY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
    Kremer, Andreas E.
    Bowlus, Christopher L.
    Bedossa, Pierre
    Pares, Albert
    Forman, Lisa M.
    Drenth, Joost P. H.
    Ryder, Stephen
    Terracciano, Luigi
    Jin, Yuying
    Liberman, Alexander
    Pencek, Richard
    MacConell, Leigh
    Pockros, Paul J.
    GUT, 2019, 68 : A110 - A111
  • [3] LONG-TERM EFFECTS OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS ON INFLAMMATORY MARKERS
    Hirschfield, Gideon M.
    Nevens, Frederik
    Shiffman, Mitchell L.
    Drenth, Joost P. H.
    Bowlus, Christopher L.
    Vargas, Victor
    Andreone, Pietro
    Ryder, Stephen
    Liberman, Alexander
    Malecha, Elizabeth Smoot
    MacConell, Leigh
    Trauner, Michael
    GUT, 2019, 68 : A115 - A116
  • [4] Long-Term Obeticholic Acid (OCA) treatment associated with reversal or stabilization of fibrosis/cirrhosis in patients with Primary Biliary Cholangitis (PBC)
    Bowlus, C.
    Pockros, P.
    Kremer, A. E.
    Pares, A.
    Forman, L.
    Drenth, J. P.
    Ryder, S.
    Malecha, E. S.
    Pencek, R.
    Iloeje, U.
    Macconell, L.
    Shapiro, D.
    Pierre, B.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S111 - S112
  • [5] Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis
    Bowlus, Christopher L.
    Pockros, Paul J.
    Kremer, Andreas E.
    Pares, Albert
    Forman, Lisa M.
    Drenth, Joost P. H.
    Ryder, Stephen D.
    Terracciano, Luigi
    Jin, Yuying
    Liberman, Alexander
    Pencek, Richard
    Iloeje, Uche
    MacConell, Leigh
    Bedossa, Pierre
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (05) : 1170 - +
  • [6] Long-Term Clinical Impact and Cost-Effectiveness of Obeticholic Acid for the Treatment of Primary Biliary Cholangitis
    Samur, Sumeyye
    Klebanoff, Matthew
    Banken, Reiner
    Pratt, Daniel S.
    Chapman, Rick
    Ollendorf, Daniel A.
    Loos, Anne M.
    Corey, Kathleen
    Hur, Chin
    Chhatwal, Jagpreet
    HEPATOLOGY, 2017, 65 (03) : 920 - 928
  • [7] Long-term Clinical Outcomes and Cost-Effectiveness of Obeticholic Acid for Treatment of Primary Biliary Cholangitis
    Samur, Sumeyye
    Hur, Chin
    Klebanoff, Matthew
    Pratt, Daniel S.
    Banken, Reiner
    Chapman, Richard H.
    Ollendorf, Daniel A.
    Chhatwal, Jagpreet
    HEPATOLOGY, 2016, 64 : 54A - 54A
  • [8] Obeticholic acid for the treatment of primary biliary cholangitis
    Ali, Ahmad H.
    Lindor, Keith D.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (13) : 1809 - 1815
  • [9] Long-term assessment of the effects of obeticholic acid in patients with primary biliary cholangitis on immune and inflammatory markers
    Hirschfield, Gideon
    Nevens, Frederik
    Shiffman, Mitchell
    Drenth, Joost Ph
    Bowlus, Christopher
    Vargas Blasco, Victor Manuel
    Andreone, Pietro
    Liberman, Alexander
    Malecha, Elizabeth Smoot
    Macconell, Leigh
    Trauner, Michael
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E395 - E395
  • [10] LONG-TERM SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS
    Peters, Y.
    Hooshmand-rad, R.
    Pencek, R.
    Owens-grillo, J.
    Marmon, T.
    Macconell, L.
    Picaro, L. A.
    Adorini, L.
    Shapiro, D.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E117 - E118
12345